Human Investing LLC Abb Vie Inc. Transaction History

Human Investing LLC

$550 Million
Q3 2024

A detailed history of Human Investing LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Human Investing LLC holds 13,722 shares of ABBV stock, worth $2.41 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

13,722

Previous 13,648 0.54%

Holding current value

$2.41 Million

Previous $2.34 Million 15.77%

% of portfolio

0.49%

Previous 0.45%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $12,124 - $14,750	74 Added 0.54%	13,722 $2.71 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $176,305 - $205,885	-1,139 Reduced 7.7%	13,648 $2.34 Million
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $8,310 - $9,469	-52 Reduced 0.35%	14,787 $2.69 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $102,787 - $115,762	-747 Reduced 4.79%	14,839 $2.3 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $7,614 - $8,815	57 Added 0.37%	15,586 $2.32 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $386,929 - $481,508	-2,920 Reduced 15.83%	15,529 $2.09 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $203,032 - $233,822	-1,404 Reduced 7.07%	18,449 $2.94 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $436,229 - $523,153	-3,154 Reduced 13.71%	19,853 $0
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $91,665 - $105,134	-683 Reduced 2.88%	23,007 $3.09 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $101,563 - $129,120	-738 Reduced 3.02%	23,690 $3.63 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $766,407 - $950,896	-5,807 Reduced 19.21%	24,428 $3.96 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $57,475 - $72,722	-535 Reduced 1.74%	30,235 $4.09 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $62,350 - $70,777	-586 Reduced 1.87%	30,770 $3.32 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $22,514 - $25,082	214 Added 0.69%	31,356 $3.53 Million
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $379,021 - $417,257	-3,705 Reduced 10.63%	31,142 $3.37 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $691,006 - $932,931	-8,585 Reduced 19.77%	34,847 $3.73 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $314,172 - $368,735	-3,657 Reduced 7.77%	43,432 $3.8 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $225,025 - $301,118	-3,067 Reduced 6.11%	47,089 $4.62 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $443,244 - $672,012	-6,872 Reduced 12.05%	50,156 $3.82 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $75,952 - $95,033	-1,053 Reduced 1.81%	57,028 $5.05 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $5,983 - $7,193	-95 Reduced 0.16%	58,081 $4.4 Million
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $30,353 - $38,798	-462 Reduced 0.79%	58,176 $4.23 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $2.18 Million - $2.57 Million	28,300 Added 93.28%	58,638 $4.73 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $2.36 Million - $2.91 Million	30,338 New	30,338 $2.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.

Account

Human Investing LLC Abb Vie Inc. Transaction History